Intravenous immunoglobulins as a treatment for alzheimers disease: Rationale and current evidence

Richard Dodel, Frauke Neff, Carmen Noelker, Refik Pul, Yansheng Du, Michael Bacher, Wolfgang Oertel

Research output: Contribution to journalReview article

96 Scopus citations

Fingerprint Dive into the research topics of 'Intravenous immunoglobulins as a treatment for alzheimers disease: Rationale and current evidence'. Together they form a unique fingerprint.

Medicine & Life Sciences